2D Structure
loading...
2D chemical structural formula diagram.
3D Structure
loading...
This 3D model represents a theoretically simulated conformation and is for reference only.
Check the
BMS-986165 (Deucravacitinib)
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
| IUPAC Name | 6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide | |
|---|---|---|
| CAS Number | 1609392-27-9 | |
| Molecular Formula |
C20H19D3N8O3 |
|
| Molecular Weight (MW) | 425.46 | |
| SMILES | CNC(=O)C1=NN=C(C=C1NC2=CC=CC(=C2OC)C3=NN(C=N3)C)NC(=O)C4CC4 | |
| InChIKey | BZZKEPGENYLQSC-FIBGUPNXSA-N |
|
Concentration
Volume
Mass
|
|---|
Batch:
All in vitro solubility values are batch-tested experimental data (non-literature values).
| Solvent | Solubility & Note |
|---|---|
| DMSO |
30 mg/mL
(70.51 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
29 mg/mL
(68.16 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
85 mg/mL
(199.78 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
Q: Why does a DMSO stock precipitate in media/saline?
A: It is caused by unheated aqueous media (supersaturation), local solvent shock, or incorrect mixing sequence.
How to fix it?
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
- BMS-986165 (Deucravacitinib) Mechanism of Action: TYK2 Inhibition in Immune Cell Research
- BMS-986165 (Deucravacitinib) Clinical Trials
- BMS-986165 (Deucravacitinib): Selectivity & Specificity
- BMS-986165 (Deucravacitinib) Working Concentration | Cell Culture | Treatment
- BMS-986165 (Deucravacitinib) Solubility in DMSO
- BMS-986165 (Deucravacitinib) Stock Solution
- BMS-986165 (Deucravacitinib) Storage
- BMS-986165 (Deucravacitinib) Stability
- BMS-986165 (Deucravacitinib) Combination Database
- BMS-986165 (Deucravacitinib) Molecular Weight
- BMS-986165 (Deucravacitinib) SMILES
- BMS-986165 (Deucravacitinib) CAS Number
- BMS-986165 (Deucravacitinib) IC50 for Cell-based and Cell-free Assays
- BMS-986165 (Deucravacitinib) Cayman (33524)? Try a better option.
- BMS-986165 (Deucravacitinib) MedChemExpress (HY-117287)? Try a better option.
- BMS-986165 (Deucravacitinib) Abmole (M4138)? Try a better option.
- BMS-986165 (Deucravacitinib) AdooQ (A18726)? Try a better option.
- BMS-986165 (Deucravacitinib) TargetMol (T14687)? Try a better option.
- BMS-986165 (Deucravacitinib) SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.